NCT03788668

Brief Summary

Aim of the study To determine the exact role of hyoid bone suspension surgery in splinting lateral pharyngeal wall in the era of the lateral pharyngoplasty

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
31

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 26, 2018

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 27, 2018

Completed
3 months until next milestone

Study Start

First participant enrolled

April 1, 2019

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2020

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2021

Completed
Last Updated

February 26, 2019

Status Verified

February 1, 2019

Enrollment Period

1.8 years

First QC Date

December 26, 2018

Last Update Submit

February 25, 2019

Conditions

Keywords

Hyoid suspensionBarbed reposition pharyngoplasty

Outcome Measures

Primary Outcomes (5)

  • Apnea hypopnea index (AHI)

    Number of apneas and hypopneas recorded during sleep is an index used to indicate the severity of sleep apnea. It is represented by the number of apnea and hypopnea events per hour of sleep. The apneas (pauses in breathing) must last for at least 10 seconds and be associated with a decrease in blood oxygenation. Minimal: AHI \< 5 per hour Mild: AHI ≥ 5, but \< 15 per hour Moderate: AHI ≥ 15, but \< 30 per hour Severe: AHI ≥ 30 per hour decrease in the AHI indicate better outcome

    4 months after intervention

  • lowest O2 saturation index (LSO2)

    Lowest 02 saturation during sleep Increase of this parameter indicate better outcome

    4 months after intervention

  • mean O2 saturation

    Increase this parameter indicate better outcome

    4 months after intervention

  • percentage of sleep time with O2 saturation below 90% (CT90%)

    Decrease in this parameter indicate better outcome

    4 months after intervention

  • Degree of airway obstruction with Drug Induced Sleep Endoscopy (DISE)

    Degree of obstruction will be evaluated using grading system Grade 1 (0-25%) of airway is obstructed Grade 2 (25-50%) of airway obstructed Grade 3 (50-75%) of airway is obstructed Grade 4 (75-100%) of airway is obstructed Decrease in this parameter indicate better outcome

    4 months after intervention

Secondary Outcomes (1)

  • Day time sleepiness will be assessed using Epworth sleepiness score (ESS)

    4 months after intervention

Study Arms (2)

Hyoid suspension with barbed reposition pharyngoplasty

ACTIVE COMPARATOR
Procedure: Hyoid suspension

barbed reposition pharyngoplasty

NO INTERVENTION

Interventions

Hyoid suspension will be done with barbed reposition pharyngoplasty

Hyoid suspension with barbed reposition pharyngoplasty

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Adult patients of both sexes between 18-60 years old.
  • Moderate to severe obstructive sleep apnea diagnosed by sleep study with apnea hypopnea index (AHI) \> 15/h.
  • Body mass index (BMI) \<35.
  • Refusing or intolerable to use continuous positive airway pressure.
  • Lateral pharyngeal wall collapse diagnosed by drug induced sleep endoscopy.
  • Patients who underwent previous tonsillectomy, adenoidectomy or previous nasal surgeries can be included.

You may not qualify if:

  • Patients who are unfit for surgeries.
  • Patients who are tolerable to continuous positive airway pressure.
  • Patients who underwent any palatal, pharyngeal, oral, mandibular, maxillofacial surgeries.
  • Patients with central sleep apnea and neurological syndromes.
  • Patients with neck, cervical vertebral pathologies and hypothyroidism.
  • Patients who had facial skeletal abnormalities.
  • Patients who had kissing tonsils or adenoids or huge tongue base.
  • Patients who have other level of obstruction (beside oropharyngeal lateral wall collapse and hypopharyngeal retro lingual obstruction) will be excluded or have this level of obstruction completely managed before recruitment in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assiut University Hospital

Asyut, 71516, Egypt

Location

MeSH Terms

Conditions

Sleep Apnea, Obstructive

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Study Officials

  • Ahmed Saleh, MSc

    Otorhinolaryngology Specialist Assiut University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, INVESTIGATOR
Masking Details
Neither the pulmonologist or the phoniatracian or the surgeon who will befrom post operative sleep study, post operative nasopharyngoscopy and post operative sleep endoscopy will know the type of operation performed to the patients.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Otorhinolaryngology Specialist

Study Record Dates

First Submitted

December 26, 2018

First Posted

December 27, 2018

Study Start

April 1, 2019

Primary Completion

December 31, 2020

Study Completion

June 1, 2021

Last Updated

February 26, 2019

Record last verified: 2019-02

Locations